Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy

被引:14
|
作者
Bedke, Jens [1 ]
Chun, Felix K-H [3 ]
Merseburger, Axel [4 ]
Scharpf, Marcus [2 ]
Kasprzyk, Kathrin [1 ]
Schilling, David [1 ]
Sievert, Karl-Dietrich [1 ]
Stenzl, Arnulf [1 ]
Kruck, Stephan [1 ]
机构
[1] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Pathol, D-72076 Tubingen, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[4] Hannover Med Sch, Dept Urol & Urooncol, Hannover, Germany
关键词
renal cell cancer; systemic inflammation; biomarkers; CRP; WBC; threshold; predictive accuracy; CANCER-SPECIFIC SURVIVAL; VALIDATION; BIOMARKER; MORTALITY; IMPACT; MODEL;
D O I
10.1111/j.1464-410X.2012.11642.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To re-evaluate the prognostic and predictive significance of the preoperative white blood cell (WBC) count and C-reactive protein (CRP) that independently predicts patient prognosis and to determine optimal threshold values for CRP. PATIENTS AND METHODS From 1996 to 2005, 327 patients with surgery for clear cell renal cell carcinoma were retrospectively evaluated. Cox proportional hazard models were used, adjusted for the effects of tumour stage, size, Fuhrman grade and Karnofsky index, to evaluate the prognostic significance of WBC count and CRP and to identify threshold values. Identified thresholds were correlated with clinicopathological parameters and used to estimate cancer-specific survival. To prove any additional predictive accuracy of the identified threshold it was compared with a clinicopathological base model using the Harrell concordance index (c-index). RESULTS In univariable analyses WBC count was a significant prognostic marker at a concentration of 9.5/mu L (hazard ratio [HR] 1.83) and 11.0/mu L (HR 2.09) and supported CRP values of 0.25 mg/dL (HR 6.47, P < 0.001) and 0.5 mg/dL (HR 7.15, P < 0.001) as potential threshold values. If adjusted by the multivariable models WBC count showed no clear breakpoint, but a CRP value of 0.25 mg/dL (HR 2.80, P = 0.027) proved to be optimal. Reduced cancer-specific survival was proved for CRP 0.25 mg/dL (median 69.9 vs 92.3 months). Median follow-up was 57.5 months with 72 (22%) tumour-related deaths. The final model built by the addition of CRP 0.25 mg/dL did not improve predictive accuracy (c-index 0.877) compared with the clinicopathological base model (c-index 0.881) which included TNM stage, grading and Karnofsky index. CONCLUSIONS Multivariable analyses revealed that an optimal breakpoint of CRP at a value of 0.25 mg/dL was best to stratify patients at risk of cancer-specific mortality, but CRP 0.25 mg/dL added no additional information in the prediction model. Therefore we cannot recommend measuring CRP as the traditional parameters of TNM stage, grading and Karnofsky index are already of high predictive accuracy.
引用
收藏
页码:E771 / E777
页数:7
相关论文
共 50 条
  • [31] Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
    Carril-Ajuria, Lucia
    Santos, Maria
    Maria Roldan-Romero, Juan
    Rodriguez-Antona, Cristina
    de Velasco, Guillermo
    CANCERS, 2020, 12 (01)
  • [32] The miR-200 family as prognostic markers in clear cell renal cell carcinoma
    Saleeb, Rola
    Kim, Sung Sun
    Ding, Qiang
    Scorilas, Andreas
    Lin, Sicheng
    Khella, Heba W. Z.
    Boulos, Carl
    Ibrahim, Gena
    Yousef, George M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (12) : 955 - 963
  • [33] ATRX protein is a potential prognostic marker in clear cell renal cell carcinoma
    Baek, Jin A.
    Jang, Nu-Ri
    Shim, Young-Ran
    Gu, Mi-Jin
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (03) : 598 - 603
  • [34] Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients
    Takamatsu, Kimiharu
    Mizuno, Ryuichi
    Tanaka, Nobuyuki
    Takeda, Toshikazu
    Morita, Shinya
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Shinojima, Toshiaki
    Kikuchi, Eiji
    Asanuma, Hiroshi
    Oyama, Masafumi
    Mikami, Shuji
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (09) : 1069 - 1074
  • [35] Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
    Orietta Dalpiaz
    Theresa Luef
    Maximilian Seles
    Michael Stotz
    Tatjana Stojakovic
    Karl Pummer
    Richard Zigeuner
    Georg C Hutterer
    Martin Pichler
    British Journal of Cancer, 2017, 116 : 85 - 90
  • [36] Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients
    Ali, Sarfraz
    Yin-Goen, Qiqin
    Johnson, Timothy V.
    Han, Wei
    Johnson, Nicole A.
    Harris, Wayne B.
    Marshall, Fray F.
    Young, Andrew N.
    Master, Viraj A.
    Osunkoya, Adeboye O.
    TUMOR BIOLOGY, 2011, 32 (02) : 375 - 380
  • [37] Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma
    Khandavilli, Sunil D.
    Ceallaigh, Padraig O.
    Lloyd, Christopher J.
    Whitaker, Rhiannon
    ORAL ONCOLOGY, 2009, 45 (10) : 912 - 914
  • [38] C-reactive protein estimation does not improve accuracy in the diagnosis of acute appendicitis in pediatric patients
    Kim, Elizabeth
    Subhas, Gokulakkrishna
    Mittal, Vijay K.
    Golladay, Eustace S.
    INTERNATIONAL JOURNAL OF SURGERY, 2009, 7 (01) : 74 - 77
  • [39] C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery
    Ishiyama, Yudai
    Kondo, Tsunenori
    Ishihara, Hiroki
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Tanabe, Kazunari
    Takagi, Toshio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 969 - 976
  • [40] A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma
    Fang, Ku-Hao
    Lai, Chia-Hsuan
    Hsu, Cheng-Ming
    Huang, Ethan
    Tsai, Ming-Shao
    Chang, Geng He
    Lee, Yi-Chan
    Tsai, Yao-Te
    PEERJ, 2020, 8